Artisan Partners’s Relay Therapeutics RLAY Stock Holding History

Artisan Partners’s Portfolio RLAY Stock Details RLAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-294,726	Closed	-$4.85M	–	334
2023 Q1	$4.85M	Sell	294,726 -728	-0.2%	-$13.1K	0.01%	300
2022 Q4	$4.41M	Sell	295,454 -10,172	-3%	-$195K	0.01%	298
2022 Q3	$6.84M	Buy	305,626 +1,718	+0.6%	+$37.7K	0.01%	290
2022 Q2	$5.09M	Sell	303,908 -146	-0%	-$3.13K	0.01%	301
2022 Q1	$9.1M	Buy	+304,054	New	+$7.38M	0.01%	303

Other funds holding RLAY

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Artisan Partners's RLAY Position: Q2 2023 in Review

Artisan Partners sold out of Relay Therapeutics (RLAY) in Q2 2023, closing a stake of 294,726 shares — an estimated $4.85M sold.

Artisan Partners first reported a position in RLAY in Q1 2022 and held it in 5 quarters. The position peaked at $9.1M in Q1 2022. 161 funds tracked by Wall St. Rank hold RLAY as of Q2 2023.

Artisan Partners reported no remaining Relay Therapeutics position as of Q2 2023 after selling out during the quarter.
Artisan Partners sold 294,726 Relay Therapeutics shares in Q2 2023, an estimated $4.85M.
Artisan Partners first reported a position in Relay Therapeutics in Q1 2022 and held it in 5 quarters.
Artisan Partners's Relay Therapeutics position peaked at $9.1M in Q1 2022.
161 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2023.

Based on Artisan Partners's 13F filing for Q2 2023, filed 10 Aug 2023.